CNBC’s Jim Cramer delivers his daily Mad Dash.

"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been ...

July 7 (Reuters) - Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the U.S., adding to an activity rebound in the initial public offering ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Like tectonic plates colliding, humanism and the humanities are confronting movements that question long-held definitions of ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

Pegasus Tech Ventures and Ohayo Dairy Products Launch US $50M Corporate Venture Capital Fund to Accelerate Innovation and Global Expansion ...

IBB, one of the largest exchange-traded funds focused on biotechnology, manages approximately $8.28 billion in assets and ...

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and ...

Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough ...

In a paper published in Proceedings of the National Academy of Sciences, researchers from Technion and Tel Aviv University ...